TTRX logo

Turn Therapeutics Inc.

TTRX
Healthcare|Biotechnology|US
$9.48
+0.54 (+6.04%)
DCF Value
$0.18
Cash / Share
$0.35

Ownership Breakdown

36.4%
Float
30.4M
Shares Outstanding
11.1M
Float Shares

Major Holders (1)

Combined: 52.8%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Bradley BurnamIndividual52.76%15,716,260Apr 6, 202613D/G